SCHEMBL6233302

SCHEMBL6233302

C(=NCCN1CCOCC1)=NC1CCCCC1.Cc1ccc(S(=O)(=O)O)c([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.45
ALDH1A1 P00352 6/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
KDM4E B2RXH2 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MCOLN3 Q8TDD5 1/20 0.40
THRB P10828 2/20 0.37
MAPT P10636 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 1/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL335422 0.88 CYP1A2 (0.59) CYP1A2CYP2C9ALDH1A1THRBMAPT
SCHEMBL31278334 0.88 CYP1A2 (0.59) CYP1A2CYP2C9ALDH1A1THRBMAPT
SCHEMBL6233308 0.86 CYP1A2 (0.55) CYP1A2CYP2C9ALDH1A1NPC1RAB9A
SCHEMBL9436866 0.86 CYP1A2 (0.59) CYP1A2CYP2C9ALDH1A1NPC1RAB9A
SCHEMBL3459786 0.85 CYP1A2 (0.65) CYP1A2CYP2C9ALDH1A1NPC1KDM4E
SCHEMBL4988124 0.85 CYP1A2 (0.55) CYP1A2CYP2C9ALDH1A1NPC1RAB9A
P-Xylene SCHEMBL3752326 0.84 CYP1A2 (0.70) CYP1A2CYP2C9ALDH1A1SMN1; SMN2NPSR1
SCHEMBL4015131 0.81 CYP1A2 (0.61) CYP1A2CYP2C9ALDH1A1NPC1SMN1; SMN2
SCHEMBL335424 0.81 CYP1A2 (0.61) CYP1A2CYP2C9ALDH1A1KDM4EGAA
SCHEMBL10752281 0.80 CYP1A2 (0.58) CYP1A2CYP2C9ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004092181-A9 HETEROCYCLIC MCHR1 ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2005-01-27 WO disclosed